MedPath

Sulodexide

Generic Name
Sulodexide
Drug Type
Biotech
CAS Number
57821-29-1
Unique Ingredient Identifier
75HGV0062C

Overview

Sulodexide is a mixture of glycosaminoglycans (GAGs) composed of dermatan sulfate (DS) and fast moving heparin (FMH).

Background

Sulodexide is a mixture of glycosaminoglycans (GAGs) composed of dermatan sulfate (DS) and fast moving heparin (FMH).

Indication

Sulodexide has been used clinically for the prophylaxis and treatment of vascular diseases with increased risk of thrombosis, including intermittent claudication, peripheral arterial occlusive disease and post-myocardial infarc-tion. Also investigated in the treatment of diabetic kidney disease and diabetic neuropathy. New anti-inflammatory properties have also extended its use in venous disease.

Associated Conditions

  • Venous Leg Ulcer (VLU)
  • Chronic Venous Ulcers

Clinical Trials

Phase 3
Posted: 2025/05/21
Sponsor:
Xijing Hospital
Not Applicable
Not yet recruiting
Posted: 2022/12/16
Sponsor:
Chengdu University o...
Phase 3
Completed
Posted: 2022/05/12
Sponsor:
Centro Medico del No...
Phase 4
Posted: 2022/02/23
Sponsor:
Pirogov Russian Nati...
Phase 3
Recruiting
Posted: 2021/08/13
Sponsor:
Value Outcomes Ltd.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath